• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[胃癌合并骨髓播散性癌病的有效术后化疗]

[Effective postoperative chemotherapy of gastric cancer associated with disseminated carcinomatosis of the bone marrow].

作者信息

Higashino Y, Nakamura T, Kato M, Asano E, Akimoto R, Uchida H, Mukawa A, Nagakawa T

出版信息

Gan No Rinsho. 1985 Sep;31(11):1456-62.

PMID:3934424
Abstract

A 35-year-old woman tuffering from gastric cancer associated with disseminated carcinomatosis of the bone marrow is reported. Total gastrectomy combined with splenectomy and distal pancreatectomy was performed. The patient was treated with mitomycin C, FT-207, OK-432, and PSK. But serum ALP (alkaline phosphatase) and CEA (carcinoembryonic antigen) values showed gradual elevations followed by deterioration of the patient's general condition. Consequently, chemotherapy program consisting of 5-fluorouracil, Adriamycin (intra-arterially), and cisplatin (intravenously) was initiated. Serum CEA and ALP values were considerably improved, and patient was restored to a better condition. She survived 17 months and died of disseminated intravascular coagulation.

摘要

报告了一名35岁患有胃癌并伴有骨髓播散性癌病的女性。实施了全胃切除术联合脾切除术和远端胰腺切除术。患者接受了丝裂霉素C、替加氟(FT - 207)、溶链菌制剂(OK - 432)和云芝多糖K(PSK)治疗。但血清碱性磷酸酶(ALP)和癌胚抗原(CEA)值逐渐升高,随后患者的一般状况恶化。因此,启动了由5 - 氟尿嘧啶、阿霉素(动脉内给药)和顺铂(静脉内给药)组成的化疗方案。血清CEA和ALP值显著改善,患者恢复到较好状态。她存活了17个月,死于弥散性血管内凝血。

相似文献

1
[Effective postoperative chemotherapy of gastric cancer associated with disseminated carcinomatosis of the bone marrow].[胃癌合并骨髓播散性癌病的有效术后化疗]
Gan No Rinsho. 1985 Sep;31(11):1456-62.
2
[Advanced gastric cancer with DIC and multiple bone metastasis treated with surgical resection and chemotherapy].
Gan To Kagaku Ryoho. 1987 Jun;14(6 Pt 1):1921-5.
3
[A case of advanced gastric cancer responding to chemotherapy and radiotherapy].[一例对化疗和放疗有反应的晚期胃癌病例]
Gan To Kagaku Ryoho. 1996 Mar;23(4):491-4.
4
[A cancer of unknown primary site with diffuse metastasis to the bone marrow treated effectively with FAM combination chemotherapy].[原发部位不明的癌症伴骨髓弥漫性转移,采用FAM联合化疗有效治疗]
Gan To Kagaku Ryoho. 1988 May;15(5):1783-6.
5
[Case report--postoperative continuous intraarterial infusion of small doses of 5-FU successfully controlled residual tumor and liver metastasis of stage IV gastric cancer].[病例报告——术后小剂量5-氟尿嘧啶持续动脉内输注成功控制IV期胃癌残留肿瘤及肝转移]
Gan To Kagaku Ryoho. 2005 Oct;32(10):1469-72.
6
[A case of advanced gastric cancer with simultaneous multiple bone metastases and double occurrence of disseminated intravascular coagulation successfully controlled with combined chemotherapy].[一例晚期胃癌伴同时多发骨转移及两次发生弥散性血管内凝血经联合化疗成功控制的病例]
Gan To Kagaku Ryoho. 2004 Mar;31(3):393-8.
7
[Clinical study of PSK as an adjuvant immunochemotherapeutic agent against gastric cancer].[PSK作为胃癌辅助免疫化疗药物的临床研究]
Gan To Kagaku Ryoho. 1986 Aug;13(8):2532-7.
8
[A multi-institutional study on postoperative adjuvant immunochemotherapy of gastric cancer].[一项关于胃癌术后辅助免疫化疗的多机构研究]
Gan To Kagaku Ryoho. 1985 Sep;12(9):1850-63.
9
[A case of inoperable advanced gastric cancer with effective treatment by local administration of OK-432, intra-abdominal administration of CDDP, and long-term high-dose mitomycin C, and UFT].一例无法手术的晚期胃癌通过局部注射OK-432、腹腔注射顺铂、长期大剂量使用丝裂霉素C和优福定进行有效治疗的病例
Gan To Kagaku Ryoho. 1991 Jun;18(7):1199-202.
10
[Successful treatment of advanced gastric cancer by combined cisplatinum, mitomycin C and 5-FU administration. A case report].[顺铂、丝裂霉素C与5-氟尿嘧啶联合给药成功治疗晚期胃癌。病例报告]
Gan To Kagaku Ryoho. 1987 Mar;14(3 Pt 1):728-31.

引用本文的文献

1
Case Report: A rare case of MET-amplified gastric cancer with systemic metastasis: remarkable efficacy of crizotinib and the role of precision medicine.病例报告:一例罕见的伴有全身转移的MET扩增型胃癌:克唑替尼的显著疗效及精准医学的作用
Front Oncol. 2025 Aug 8;15:1555801. doi: 10.3389/fonc.2025.1555801. eCollection 2025.
2
Non-tissue factor procoagulants in cancer cells.癌细胞中的非组织因子促凝剂。
Cancer Metastasis Rev. 1992 Nov;11(3-4):267-82. doi: 10.1007/BF01307182.